Stock of the Day

Seer (SEER)

$2.28

+$0.10 (+4.4%)

Market Cap: $133.93M

About Seer

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Recent News

• Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults (msn.com)
• Doc-turned-seer of Telugu origin to head Courtallam peetham (msn.com)
• Seer, Inc. and Korea University Launch First Large-Scale Study to Identify Early-Onset Cancer Biomarkers Using Proteograph ONE Assay (quiverquant.com)
• Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults (globenewswire.com)
• Seer Jagadguru Rambhadracharya seeks PoK as ‘guru dakshina’ from Army chief general Upendra Dwivedi (msn.com)